Table 4. Associations between regional cerebrovascular disease, Aβ isoforms and amyloid PET, pooled data from the CHE, SCD and MCI groups.
Group | Parameter | ARWMC total | ARWMC frontal | ARWMC parieto- occipital | ARWMC temporal | ARWMC infratententorial |
---|---|---|---|---|---|---|
CHE, SCD, MCI | CSF Aβ38 | −0.142*** | −0.130*** | −0.142*** | −0.155*** | −0.013 |
CSF Aβ40 | −0.121** | −0.111** | −0.122** | −0.137** | 0.019 | |
CSF Aβ42 | −0.040 | −0.026 | −0.073 | −0.088* | 0.031 | |
Composite SUVR | 0.094 | 0.088 | 0.084 | 0.136* | 0.015 |
SVD was estimated as the total and regional white matter lesion score according to the ARWMC scale. Values represent standardized beta (linear regression, ARWMC score) with 95% confidence intervals; prior to analysis, the natural logarithm of the CSF and PET parameters was calculated to ensure normal distribution. Values are corrected for age, sex and hippocampal volume; the latter was determined using Adaboost, the mean value of the left and right hippocampus was normalized using the scaling factor provided by this software to account for head size differences. *p < 0.05, **p < 0.0125, ***p > 0.001.
Only p-values < 0.0125 should be considered significant according to Bonferroni-adjustment.